Transitional Cell Carcinoma of the Renal Pelvis and Ureter
📧 Sign up to get email alerts when something new happens for Transitional Cell Carcinoma of the Renal Pelvis and Ureter.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-06-22Clinical Trial Update: Two-Drug Combination Chemotherapy Compared With Four-Drug Combination Chemotherapy in Treating Patients With Advanced Cancer of the Urothelium [Phase 3]
Phase 3 trial comparing two-drug vs four-drug chemotherapy regimens in advanced urothelial cancer (bladder cancer and related urothelial can…
-
CLINICAL_TRIALS trial_result · 2019-05-16Clinical Trial Update: Carboplatin and Gemcitabine Hydrochloride With or Without Vandetanib as First-Line Therapy in Treating Patients With Locally Advanced or Metastatic Urinary Tract Cancer [Phase 2]
Phase 2 trial evaluating carboplatin and gemcitabine with or without vandetanib as first-line therapy for locally advanced or metastatic uri…
-
CLINICAL_TRIALS trial_result · 2018-08-10Clinical Trial Update: Gemcitabine, Paclitaxel, and Cisplatin in Treating Patients With Advanced Cancer of the Urothelium [Phase 2]
Phase 2 trial evaluating gemcitabine, paclitaxel, and cisplatin for advanced urothelial cancer (bladder cancer and transitional cell cancer …
-
CLINICAL_TRIALS trial_result · 2016-02-24Clinical Trial Update: S0028, Gemcitabine and Paclitaxel in Treating Patients With Advanced or Recurrent Cancer of the Urinary Tract [Phase 2]
Phase 2 SWOG trial of gemcitabine and paclitaxel in advanced or recurrent urinary tract cancers (bladder cancer, transitional cell carcinoma…
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Combination Chemotherapy Plus Filgrastim in Treating Patients With Locally Recurrent or Advanced Urothelium Cancer [Phase 2]
Phase 2 trial evaluating combination chemotherapy with filgrastim for locally recurrent or advanced urothelial cancer, including bladder can…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2013-12-04Clinical Trial Update: Fluorouracil in Treating Patients With Recurrent or Metastatic Bladder Cancer [Phase 2]
Phase 2 study of fluorouracil in recurrent or metastatic bladder cancer, including transitional cell carcinoma of the renal pelvis and urete…
-
CLINICAL_TRIALS trial_result · 2013-09-05Clinical Trial Update: Oxaliplatin in Treating Patients With Metastatic Bladder Cancer [Phase 2]
Phase 2 clinical trial update showing oxaliplatin used for metastatic bladder cancer; the study has completed.
-
CLINICAL_TRIALS trial_result · 2013-08-12Clinical Trial Update: Pazopanib Hydrochloride in Treating Patients With Metastatic Urethral Cancer or Bladder Cancer That Has Relapsed or Not Responded to Treatment [Phase 2]
A Phase 2 clinical trial evaluating pazopanib hydrochloride in patients with metastatic bladder cancer, urethral cancer, or transitional cel…
-
CLINICAL_TRIALS trial_result · 2013-07-10Clinical Trial Update: Combination Chemotherapy Following Surgery in Treating Patients With Urinary Tract Cancer [Phase 2]
This clinical trial update reports the completion of a Phase 2 study evaluating combination chemotherapy after surgery for bladder cancer an…
-
CLINICAL_TRIALS trial_result · 2013-07-03Clinical Trial Update: Combination Chemotherapy in Treating Patients With Metastatic or Locally Advanced Bladder Cancer [Phase 1, Phase 2]
A Phase 1/2 clinical trial investigating a combination chemotherapy regimen for metastatic or locally advanced bladder cancer has completed.…
-
CLINICAL_TRIALS trial_result · 2013-07-03Clinical Trial Update: Combination Chemotherapy in Treating Patients With Advanced Bladder or Kidney Cancer [Phase 1]
A completed Phase 1 clinical trial evaluating a combination chemotherapy regimen for advanced bladder cancer and transitional cell carcinoma…
-
CLINICAL_TRIALS trial_result · 2013-06-12Clinical Trial Update: Combination Chemotherapy in Treating Patients With Transitional Cell Cancer of the Urothelium [Phase 2, Phase 3]
A Phase 2/Phase 3 clinical trial evaluating combination chemotherapy for transitional cell cancers of the urothelium has completed, includin…
-
CLINICAL_TRIALS trial_result · 2013-01-24Clinical Trial Update: Ixabepilone in Treating Patients With Advanced Urinary Tract Cancer [Phase 2]
Phase 2 clinical trial of ixabepilone in advanced urinary tract cancers has completed, evaluating its activity across several urothelial and…
-
CLINICAL_TRIALS trial_result · 2013-01-14Clinical Trial Update: Trastuzumab and Combination Chemotherapy in Treating Patients With Locally Recurrent or Metastatic Urinary Tract Cancer [Phase 2]
Phase 2 clinical trial evaluating trastuzumab with chemotherapy in locally recurrent or metastatic urinary tract cancers has completed, incl…
-
CLINICAL_TRIALS trial_result · 2012-11-02Clinical Trial Update: S0400, FR901228 in Treating Patients With Advanced Cancer of the Urothelium [Phase 2]
Phase 2 trial of Romidepsin (FR901228) in advanced urothelial cancers was terminated.
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: Nitrocamptothecin in Treating Patients With Metastatic Cancer of the Urinary Tract [Phase 2]
Phase 2 trial of Nitrocamptothecin for metastatic cancer of the urinary tract has completed.
-
CLINICAL_TRIALS trial_result · 2012-09-24Clinical Trial Update: SCH 66336 Plus Gemcitabine in Treating Patients With Advanced Cancer of the Urinary Tract [Phase 2]
A Phase 2 clinical trial evaluating SCH 66336 (lonafarnib) in combination with gemcitabine for advanced cancers of the urinary tract has com…
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: Sunitinib as Second-Line Therapy in Treating Patients With Locally Advanced or Metastatic Transitional Cell Cancer [Phase 2]
This Phase 2 trial evaluated sunitinib as second-line therapy for locally advanced or metastatic transitional cell cancer of the bladder and…